|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 401/12 | (2006.01) |
| C07D 401/14 | (2006.01) | ||
| C07D 413/14 | (2006.01) | ||
| A61K 31/5377 | (2006.01) | ||
| A61P 3/06 | (2006.01) |
| (11) | Number of the document | 2207775 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08848438.1 |
| Date of filing the European patent application | 2008-11-03 | |
| (97) | Date of publication of the European application | 2010-07-21 |
| (45) | Date of publication and mention of the grant of the patent | 2012-03-21 |
| (46) | Date of publication of the claims translation | 2012-07-25 |
| (86) | Number | PCT/EP2008/064859 |
| Date | 2008-11-03 |
| (87) | Number | WO 2009/059943 |
| Date | 2009-05-14 |
| (30) | Number | Date | Country code |
| 985456 P | 2007-11-05 | US |
| (72) |
MOGI, Muneto, US
YAMADA, Ken, US
YASOSHIMA, Kayo, US
KAWANAMI, Toshio, US
UMEMURA, Ichiro, JP
IWAKI, Yuki, US
QIN, Hongbo, JP
IMASE, Hidetomo, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | 4-benzilamino-1-karboksiacil-piperidino dariniai kaip CETP inhibitoriai, naudingi gydymui ligų, tokių kaip hiperlipidemija arba arteriosklerozė |
| 4-BENZYLAMINO-1-CARBOXYACYL-PIPERIDINE DERIVATIVES AS CETP INHIBITORS USEFUL FOR THE TREATMENT OF DISEASES SUCH AS HYPERLIPIDEMIA OR ARTERIOSCLEROSIS |
| Payment date | Validity (years) | Amount | |
| 2019-10-29 | 12 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2020-11-03 |